Page last updated: 2024-08-22

neodymium and Ocular Hypertension

neodymium has been researched along with Ocular Hypertension in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Çakmak, K; Erbil, H; Korkmaz, Ş; Mesci, C1
Brézin, AP; Bugnard, F; Dot, C; Goguillot, M; Labbé, A; Lignereux, F; Rozot, P; Schweitzer, C1
Gurnani, B; Kaur, K1
Artunay, O; Bahcecioglu, H; Rasier, R; Sengul, A; Unal, M; Yuzbasioglu, E1
Blumenthal, M; Naveh, N; Zborowsky-Gutman, L1
de Jong, PT; Leys, M; Pameijer, JH1

Trials

2 trial(s) available for neodymium and Ocular Hypertension

ArticleYear
Comparing the effects and safety of dorzolamide hydrochloride + timolol maleate versus brimonidine after neodymium-doped yttrium aluminium garnet laser capsulotomy posterior capsule opacification.
    European journal of ophthalmology, 2022, Volume: 32, Issue:5

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Capsule Opacification; Glaucoma; Humans; Intraocular Pressure; Lasers, Solid-State; Neodymium; Ocular Hypertension; Ophthalmic Solutions; Sulfonamides; Thiophenes; Timolol; Yttrium

2022
Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:5

    Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Capsule Opacification; Cataract; Cloprostenol; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Neodymium; Ocular Hypertension; Ophthalmic Solutions; Posterior Capsule of the Lens; Quinoxalines; Tonometry, Ocular

2010

Other Studies

4 other study(ies) available for neodymium and Ocular Hypertension

ArticleYear
Incidence of Retinal Detachment, Macular Edema, and Ocular Hypertension after Neodymium:Yttrium-Aluminum-Garnet Capsulotomy: A Population-Based Nationwide Study-The French YAG 2 Study.
    Ophthalmology, 2023, Volume: 130, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Capsule Opacification; Cataract Extraction; Humans; Incidence; Laser Therapy; Lens Capsule, Crystalline; Macular Edema; Middle Aged; Neodymium; Ocular Hypertension; Postoperative Complications; Retinal Detachment

2023
Re: Dot et al.: Incidence of retinal detachment, macular edema, and ocular hypertension after neodymium:yttrium-aluminum-garnet capsulotomy: a population-based nationwide study-The French YAG 2 Study (Ophthalmology. 2022;130:478-487).
    Ophthalmology, 2023, Volume: 130, Issue:12

    Topics: Glaucoma; Humans; Incidence; Macular Edema; Neodymium; Ocular Hypertension; Retinal Detachment

2023
Neodymium-YAG laser iridotomy in angle closure glaucoma: preliminary study.
    The British journal of ophthalmology, 1987, Volume: 71, Issue:4

    Topics: Aged; Edema; Eye Hemorrhage; Female; Glaucoma, Open-Angle; Humans; Laser Therapy; Male; Middle Aged; Neodymium; Ocular Hypertension; Postoperative Complications; Prospective Studies

1987
Intra ocular pressure drop after Q switched neodymium YAG laser posterior capsulotomy.
    Bulletin de la Societe belge d'ophtalmologie, 1986, Volume: 213

    Topics: Humans; Laser Therapy; Lens Capsule, Crystalline; Lens, Crystalline; Neodymium; Ocular Hypertension; Postoperative Complications; Yttrium

1986